Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 22 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Antivirals prevent post-liver transplant Hep B recurrence

In HIV/Hep B coinfected liver transplant patients, Hep B virus recurrence is successfully prevented with combination prophylaxis using Hep B immune globulin and antivirals, finds this month's Liver Transplantation.

News image

fiogf49gjkf04

The outcome of patients with Hepatitis B virus and human immunodeficiency virus (HIV) referred for liver transplantation is unknown.

A high frequency of lamivudine-resistant Hepatitis B may increase the risk of liver-related death pre-transplantation and prophylaxis failure post-transplantation.

Dr Norah Terrault and colleagues evaluated the association of lamivudine-resistant Hepatitis B virus on pre-transplant survival.

The investigative team also assessed the association of lamivudine-resistant Hepatitis B and post-transplant outcomes.

The team included 35 consecutive HIV/Hepatitis B coinfected patients referred for liver transplantation between 2000 and 2002.

At the time of referral, the median CD4 count was 273/mm, MELD was 14, and lamivudine-resistant Hepatitis B virus infection was present in 67%.

Hep B virus DNA was not detected after Hep B immune globulin plus lamivudine
Liver Transplantation

The investigators listed 26% of the referred patients, and 29% were not listed due to relative or absolute contraindications.

Those not listed were too sick for liver transplantation, or it was too early for liver transplantation, and some patients died during transplant evaluation.

Of the 9 listed patients, 4 remained listed, 1 died 18 months post-referral, and 4 were transplanted 3 to 40 months after listing.

Of 17 evaluated but not listed patients, the team reported that 5 died.

The investigators observed that all deaths were liver-related.

All the HIV/Hepatitis B coinfected patients who were transplanted, were Hepatitis B antigen negative.

The team found that the patients had undetectable Hepatitis B virus DNA levels on prophylactic therapy using Hepatitis B immune globulin plus lamivudine.

The investigators did not detect the virus DNA in patients on prophylactic therapy, with and without tenofovir or adefovir, after about 33 months follow-up.

Dr Terrault's team commented, “Late referral and the presence of lamivudine-resistant Hepatitis B virus pre-transplantation are common in referred HIV/Hepatitis B coinfected patients.”

“In these patients undergoing liver transplantation, Hepatitis B virus recurrence is successfully prevented with combination prophylaxis using Hepatitis B immune globulin and antivirals.”

Liv Transplant 2006: 12(5): 801-7
05 May 2006

Go to top of page Email this page Email this page to a colleague

 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 21 November 2017 
Prepregnancy obesity and maternal mortality
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 25 October 2017 
Fecal microbiota transplantation
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us